Introduction
============

Specific language impairment (SLI) is a developmental disorder that, in the absence of neurological deficits, affects an individual\'s spoken and/or receptive language acquisition. SLI is a common but genetically complex disorder with an estimated prevalence of up to 7%^[@bib1]^ and shows significant overlap with autism, dyslexia and ADHD, both phenotypically^[@bib2]^ and genetically.^[@bib3],\ [@bib4]^ Like many common disorders, the majority of the genetic risk for SLI is expected to be conferred by combinations of common genetic variants that is, the 'common disorder--common variant\' model.^[@bib5]^ Nonetheless, a growing body of evidence suggests that single nucleotide variants alone do not explain the heritability of complex traits (the 'missing heritability\') and that the underlying aetiology may include other factors such as copy number variants (CNVs), rare variants and epigenetic modifications.^[@bib6]^ Studies have found that individuals with autism or ADHD generally have an increased burden of rare CNVs compared with controls^[@bib7],\ [@bib8],\ [@bib9]^ and that the severity of phenotype across neurodevelopmental disorders may be positively correlated with the burden of large CNVs.^[@bib10]^ The 'burden\' of CNVs can be considered in many ways, for example, the number of CNVs an individual carries, the average size of CNVs, the total size of CNVs across the genome or the number of genes affected by CNV events. Similarly, one can filter the types of CNVs considered, restricting the investigation to rare, *de novo*, exonic or large (usually defined as \>1 Mb in the literature) events. Individuals with autism from simplex families (ie, parents and a single affected child) have been reported to carry a higher rate of *de novo* CNVs than those from multiplex families (ie, parents and multiple affected children).^[@bib11],\ [@bib12],\ [@bib13]^ Some CNVs have been associated across disorders; for example, a 600 kb microduplication on 16p11.2 has been associated with childhood apraxia of speech,^[@bib14],\ [@bib15]^ autism,^[@bib16]^ bipolar disorder and schizophrenia,^[@bib17]^ indicating that the same CNV may give different outcomes. The exact outcome has been proposed to depend on the genetic background of an individual and environmental cues. Other CNVs are not recurrent within a disorder but private to a particular family, presumably contributing to a biological pathway that is shared in other individuals.

We explore the contribution of CNVs to SLI, by studying a set of families collected by the SLI Consortium (SLIC). We compare CNV burden between independent cases and unselected population controls and examine CNV load across the wider SLIC sample set, which includes first-degree relatives of variable affection status.

Materials and methods
=====================

Inclusion criteria for SLI samples
----------------------------------

One-hundred and twenty-seven independent cases with SLI (92 males and 35 females) and 385 available first-degree relatives (parents and siblings (sibs), 192 males and 193 females from 152 families) from the UK-based SLIC were analysed for CNVs. This cohort has previously been described in detail.^[@bib18],\ [@bib19],\ [@bib20],\ [@bib21]^ The SLIC cohort consists of British nuclear families ascertained to include at least one child affected by SLI, defined as expressive and/or receptive language skills (ELS and RLS, respectively) ≥1.5 SD below the normative mean and nonverbal IQ not \>1.5 SD below that expected for their age (77.5). Language skills were measured in all children using the Clinical Evaluation of Language Fundamentals (CELF-R);^[@bib22]^ a battery of language-based tests that assess a range of traits and thus provide a broad profile of language ability in the child. Nonverbal skills were measured by the WISC Perceptual Organisation Index (a composite score derived from Picture Completion, Picture Arrangement, Block Design and Object Assembly subtests).^[@bib23]^ In the current study, independent cases were selected to represent one affected individual (as defined above) per family. All available first-degree relatives (parents and siblings) were then used to follow-up findings that were significant in the independent cases. For these follow-up analyses, siblings were classified as affected (as defined above, 37 individuals), unaffected (ELS and RLS above mean, 19 individuals) or undefined language status (if they did not meet the criteria for affected or unaffected or had missing CELF data, 105 individuals). For parents, CELF-R data were not available. However, we were able to classify parental language status using a test of non-word repetition (NWR), which has been proposed as a strong behavioural marker of SLI^[@bib24],\ [@bib25]^ and shows high sensitivity and specificity of a positive history of language difficulties in adult subjects.^[@bib26]^ Thirty-five parents were classified as affected (NWR \>1.5 SD below the mean), 27 were unaffected (NWR \>mean) and 162 had undefined language status (did not meet the criteria for affected or unaffected, or were missing NWR data). In our child cohort, the NWR measure was observed to have a moderate level of sensitivity (45% of affected children had NWR scores below −1.5 SD) and a high specificity (none of the unaffected sibs had NWR scores below −1.5 SD). Thus, although we expect the NWR measure to classify some parents with a positive history of language impairment as unknown, importantly, it is less likely to classify unaffected parents as affected. Ethical agreement for the SLIC study was given by local ethics committees, and all subjects provided informed consent.

Control samples
---------------

Two-hundred and sixty-nine healthy 'white-British\' adult population controls (115 males and 154 females), unselected in terms of language ability, were obtained from a study of gene expression in primary immune cells.^[@bib27]^ The study was approved by the Oxfordshire Research Ethics Committee (COREC reference 06/Q1605/55).

SNP genotyping
--------------

DNA was extracted from peripheral blood or buccal smears and all samples were genotyped on the Illumina HumanOmniExpress-12v1 Beadchip (San Diego, CA, USA) that contains \~750 000 SNPs. SNPs were excluded if the gentrain (genotype clustering quality) score was \<0.5 or genotyping success rate was \<95%. Samples were excluded if they had \<95% SNP genotype rate, or heterozygosity rate of ≥±2 SD or fell outside the European cluster in a principal components analysis. Importantly, all samples were genotyped on the same arrays.

CNV calling
-----------

CNVs were identified using PennCNV (16 June 2011 version)^[@bib28]^ and QuantiSNP (v2.2).^[@bib29]^ For both algorithms, CNVs were required to have at least three consecutive SNPs and a confidence value (PennCNV) or log Bayes Factor (QuantiSNP) of \>10. In PennCNV individuals with an SD for the log R ratio (LRR) \>0.35, a B-allele frequency (BAF) drift value \>0.002 or a waviness factor \>0.04 or \<−0.04 were excluded. In QuantiSNP, individuals with an average SD for the LRR \>0.3 or an SD for BAF \>0.15 were excluded.

If a CNV was predicted by both PennCNV and QuantiSNP, with a minimum intersection of 50% each way, it was considered to be of 'high confidence\' and was carried forward for analyses described below. The innermost boundaries of the two algorithm calls were used. CNVs were excluded if they spanned the centromere or telomeres.

Rare, novel and *de novo* CNV identification and validation
-----------------------------------------------------------

All 'high-confidence\' CNVs were compared against the Database for Genomic Variants (DGV; downloaded from UCSC genome browser hg19, January 2012) to identify 'rare and novel\' CNVs. Those that intersected \<50% with five or less CNVs in the DGV were considered rare. Those that did not overlap with any CNV in the DGV were classed as novel.

To detect *de novo* CNVs, 161 individuals (67 probands, 18 affected siblings, 27 unaffected siblings and 49 siblings of undefined affection status) who had genotype data available for both parents were analysed using trio and quartet algorithms in PennCNV.

All rare events \>100 kbp, all novel exonic events \>100 kbp and all *de novo* exonic events were subsequently validated by quantitative PCR using four PCR primer pairs, two outside the CNV and two within it. PCRs were performed in triplicate using iQ SYBR Green Supermix (Bio-Rad, Hercules, CA, USA) and calibrated against a control DNA that did not contain the identified CNVs and a control gene (*ZNF423*) that did not contain any CNVs within our sample set. The parents of individuals with *de novo* exonic CNVs were also examined. Copy numbers in each individual were calculated using the 2^−ΔΔCt^ method.^[@bib30]^

Statistical analysis of CNV burden
----------------------------------

'High-confidence\' CNVs, as defined above, were analysed using PLINK v1.07^[@bib31]^ to identify burden differences between independent cases and population controls. Metrics that differed significantly (empirical *P*\<0.05) were then also examined in the first-degree relatives. Burden analyses were also performed for 'rare and novel\' and the *de novo* CNVs. Empirical *P*-values were calculated using 10 000 permutations within PLINK.

PLINK was also employed to determine whether pre-defined gene sets showed enrichment for CNVs in independent cases compared with population controls. Given the phenotypic and genetic links reported between autism and SLI, we specifically interrogated 531 autism-candidate genes (compiled from Xu *et al.*^[@bib32]^and Betancur *et al.*^[@bib33]^ and the SFARI database (October 2012)). In addition, we investigated 1315 putative targets of the Foxp2 protein (as reported in Vernes *et al.*^[@bib34]^). Mutations of *FOXP2* cause developmental language disorder, and targets of this transcription factor have been implicated in language and developmental disorders.^[@bib15],\ [@bib35],\ [@bib36]^

Five candidate regions that have consistently been associated with neurodevelopmental disorders were also interrogated for CNV events and compared between independent cases (127 individuals) and population controls (269 individuals). These consisted of chromosomes 7q11.23,^[@bib37]^ 15q11-13,^[@bib15],\ [@bib16],\ [@bib17],\ [@bib38]^ 16p11.2,^[@bib38],\ [@bib39]^ 16p13.1^[@bib38]^ and 22q11.2.^[@bib38],\ [@bib39]^

Pathway analysis
----------------

WebGestalt^[@bib40]^ was used to identify gene ontology (GO) terms (Gene Ontology, version 1.2, 11 November 2012) that were enriched for genes present within 'high-confidence\' CNVs and the 'rare and novel\' CNVs between independent cases and population controls. GO categories that were enriched in the independent cases, but not the population controls, are reported. *P-*values were adjusted for multiple testing using the false discovery rate.

Results
=======

Burden analysis
---------------

1432 'high-confidence\' CNVs were identified in 127 independent cases (11.3 per individual), compared with 4081 in 385 SLIC first-degree relatives (10.6 per individual) and 2693 in 269 population control samples (10.01 per individual). A full list of all 'high-confidence\' CNVs identified in SLI cases and their first-degree relatives has been submitted to DGVa (accession estd218).

Four burden metrics (average number of CNVs, average total length of CNVs, average size of CNVs and average number of genes spanned) differed significantly between independent cases and population controls ([Table 1](#tbl1){ref-type="table"}). The average number and average total length of CNVs were driven by deletion events ([Table 1](#tbl1){ref-type="table"}) while the other two categories were significant for both deletions and duplications ([Table 1](#tbl1){ref-type="table"}). SLIC first-degree relatives (who included affected, unaffected and undefined parents and siblings) also had significantly more CNVs that were, on average, longer and covered more genes, than those observed in population controls ([Table 1](#tbl1){ref-type="table"}). The same patterns were seen when the first-degree relative sample set was restricted to include only affected, or only unaffected relatives, although the trends did not always reach significance in these smaller sample sets ([Table 1](#tbl1){ref-type="table"}). In order to explore the effect of case ascertainment method (currently based upon expressive and receptive language skills (ELS and RLS, respectively) and nonverbal IQ -- see Materials and methods) upon the observed trends, we applied an alternative definition of SLI affection within our case cohort. When independent cases were alternatively selected to have NWR scores \<1.5 SD below that expected for their age (59 individuals, 46% of cases), the same four burden metrics (average number of CNVs, average total length of CNVs, average size of CNVs and average number of genes spanned) again differed significantly between independent cases and population controls ([Table 1](#tbl1){ref-type="table"}).

Rare and novel CNVs
-------------------

Approximately 10% of the 'high-confidence\' CNVs were 'rare and novel\'. A total of 131 'rare and novel CNVs\' were identified in independent cases (1.03 per individual), 319 in SLIC first-degree relatives (0.83 per individual) and 275 in population controls (1.02 per individual; [Table 2](#tbl2){ref-type="table"}). The burden of 'rare and novel\' CNVs, for the main part, did not differ significantly between independent cases and population controls ([Table 2](#tbl2){ref-type="table"}). Although independent cases had an increased length of duplications than population controls ([Table 2](#tbl2){ref-type="table"}), these differences were less significant than those found for all 'high-confidence\' events.

Twenty 'rare\' or 'novel\' CNVs that were larger than 100 kbp were identified in the independent cases, 14 (70%) of which were exonic ([Table 3](#tbl3){ref-type="table"}), while 36 were identified in the population controls, of which 23 (64%) were exonic. The rarity of these events precludes a statistical evaluation. However, as a note of interest, these CNVs included the *NDUFB3, NIF3L1, PPEF2, CACNA2D1* and *GPC5* genes, which are expressed in the brain and/or have been implicated in neurological disorder.

Gene enrichment analysis
------------------------

No enrichment for autism-candidate genes or Foxp2 targets was observed for the 'high-confidence\', 'rare and novel\' or *de novo* CNVs in independent cases.

Pathway analysis
----------------

There were 719 genes that had GO categories defined within the 'high-confidence\' events in independent cases and 757 within population controls. For the 'rare and novel\' CNVs, 179 genes had GO categories defined within the independent cases and 176 in population controls. Pathway analyses indicated that six GO categories were significantly and specifically enriched in independent cases but not in population controls after correcting for multiple testing. 'Acetylcholine binding\' (GO:0042166, *CHRNA7, CHRNA3, ACHE* and *CHRNB4*), 'cyclic-nucleotide phosphodiesterase activity\' (GO:0004112 and GO:0004114, *PDE8A, PDE1A, PDE4D, PDE6H* and *PDE1C*) and 'MHC protein complex\' (GO:0042611, *HLA-DMA, HLA-C, HLA-H, HLA-DQA1, MICA* and *HLA-DMB*) were enriched when considering all CNV events. While the cellular components 'proteasome activator complex\' (GO:0008537, *PSME1* and *PSME2*) and 'nuclear inclusion body\' (GO:0042405, *NXF1* and *ATXN1*) were enriched in the 'rare and novel\' CNV set ([Table 4](#tbl4){ref-type="table"}).

*De novo* CNVs
--------------

Genotype data were available for both parents for 161 children (including 85 affected individuals (independent cases or affected siblings), 27 unaffected siblings and 49 individuals of undefined affection status). Analyses of these trios/quartets identified 77 putative *de novo* CNVs in 56 individuals, of whom 24 were affected (17 independent cases), 12 were unaffected and 20 had undefined affection status. Although the sample size is small, burden analysis comparisons did not find differences in the rate or size of *de novo* CNVs between the affected and unaffected individuals.

Genic *de novo* CNVs in independent cases (5 events in 4 individuals; [Table 3](#tbl3){ref-type="table"}) were all confirmed to be absent in the parents by qPCR. Four of the five events were not observed in any other individuals in this dataset. Three of these include genes of potential interest for SLI (see Discussion). Two of the *de novo* CNVs fell within regions of known structural variation in neurodevelopment; 8p23.1^[@bib41]^ and 22q11.2,^[@bib38],\ [@bib39]^ although they were smaller than the typical micro-deletion/-duplication events typically reported.

Specific candidate regions
--------------------------

Five CNV candidate regions in neurodevelopmental disorders were investigated: 7q11.23, 15q11-13, 16p11.2, 16p13.1 and 22q11.2. No CNVs were found in 7q11.23, 16p11.2 or 16p13.1 in independent cases. CNVs on 15q11-13 and 22q11.2 were found in both independent cases and population controls ([Supplementary Table](#sup1){ref-type="supplementary-material"}). The frequency of these events was similar between independent cases and population controls ([Supplementary Table](#sup1){ref-type="supplementary-material"}). All the events identified consisted of small CNVs within these sites rather than the classical large events typically associated with neurodevelopmental disorder.

Discussion
==========

An exploratory study of CNVs in individuals with SLI and their first-degree relatives was performed. Consistent, statistically significant increases in burden were found for individuals with SLI suggesting that copy number does have a role in this disorder. More specifically, our cases showed a significantly higher number of deletions, with larger CNVs and deletions that covered more genes than controls. The differences in burden appear to be primarily driven by the size of events. Our cases, on average only carried one more CNV than population controls, but each event was, on average, 12 kb longer and the total CNV length across the genome therefore totalled 200 kb more in cases than population controls. Furthermore, these events on an average, hit four more genes in the cases than population controls.

In contrast to that reported for autism and ADHD^[@bib7],\ [@bib8],\ [@bib9]^ we found only an increase in the average total length of 'rare and novel\' duplications and the average 'rare and novel\' duplication size in independent cases compared with population controls ([Table 2](#tbl2){ref-type="table"}). Furthermore, we note that the majority of CNVs observed in independent cases were \<100 kb. Sizeable events are reported to be of importance in intellectual disability^[@bib10]^ but, interestingly, not in developmental dyslexia.^[@bib10]^ Note, however that the contribution of smaller, common CNVs to dyslexia has yet to be evaluated and that the number of these events in our cohort was small.

We extended our investigations to consider CNV burden across the first-degree relatives of our independent SLI cases. We studied all available parents and siblings (regardless of their language status) as well as subsets of only affected or only unaffected relatives. We again observed a significantly increased burden of larger, genic CNVs compared with population controls ([Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}). Furthermore we found that these trends were consistent across the first-degree relatives, regardless of affection status ([Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"}).

*De novo* CNVs have been reported to be of particular importance in neurodevelopmental disorders, especially when fecundity is reduced. Although our sample set was small, we observed a similar level of *de novo* CNVs across 85 SLI cases and 27 unaffected siblings. Thus, unlike that reported for autism and schizophrenia,^[@bib11],\ [@bib37]^ we propose that *de novo* CNVs do not represent a major risk factor for SLI.

Given the data generated from this study, we hypothesise that the increased copy number burden observed in SLI occurs via a 'common disease--common variant\' model in which certain combinations of common CNV events confer the majority of CNV-based risk. In this small sample set, we find evidence that children affected by SLI carry a higher burden of common CNVs of moderate size that hit genes more often than that observed in population controls. This finding extends to the first-degree relatives of children affected by SLI, indicating that the major driving force is likely to be inherited rather than *de novo*. We did not observe a significant correlation between CNV burden and language-related phenotypic scores ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}) amongst cases and their first-degree relatives ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}), indicating that the correlation between CNV burden and absolute risk is not straightforward. Together, these data suggest that the absolute risk conferred by CNVs depends upon the position and combination of events inherited, and the genetic background of the individual, which may also include sequence variants of effect and environmental factors.

Although we did not observe an increased rate of *de novo* CNVs in cases, we do not preclude the possibility that these events are important on a case-by-case basis. A number of genes within *de novo* CNVs represent interesting candidates ([Table 3](#tbl3){ref-type="table"}). A deletion in the *ACTR2* gene was found in an independent case (SLI-45_2, [Table 3](#tbl3){ref-type="table"}) and his monozygotic twin, who was also affected, indicating that this event occurred prior to the division of the blastocyst. *ACTR2* encodes a component of the ARP2/3 complex, a reduction of which may cause abnormal neuronal and glial migration and impaired neurite extension.^[@bib42]^ One independent case (SLI-146_3, [Table 3](#tbl3){ref-type="table"}) was found to have two *de novo* events; a deletion in *CSNK1A1*, which has been related to dopamine signalling and ADHD^[@bib43]^ and a duplication within the region typically duplicated in 22q11.2 microduplication syndrome. A further case (SLI-59_3, [Table 3](#tbl3){ref-type="table"}) had a duplication that fell within the 8p23.1 duplication syndrome region, which can include language delay.^[@bib41]^ Interestingly, each of the independent cases carrying *de novo* CNVs were from simplex families, apart from the monozygotic twin described above, perhaps indicating a different mechanism of risk within isolated cases of language impairment and suggesting that clinical screening of such cases may prove fruitful.

Pathway analyses identified several GO categories of functional interest, six of which survived multiple testing (GO:0004112, GO:0004114, GO:0042166, GO:0042611, GO:0008537 and GO:0042405; [Table 4](#tbl4){ref-type="table"}). Acetylcholines (GO:0042166) act as neurotransmitters and cyclic-nucleotide phosphodiesterase enzymes (GO:0004112 and GO:0004114) are widely expressed in brain tissue.^[@bib44]^ The MHC loci (GO:0042611), *HLA-C* and *HLA-DQA1,* have been recently associated with SLI.^[@bib45]^ Proteasome activator complexes (GO:0008537) have been associated with neurodegenerative and autoimmune diseases^[@bib46]^ as have genes in the 'nuclear inclusion body\' GO category (GO:0042405; *NXF1* and *ATXN1)*.

In summary, our exploratory study found that children with SLI and their first-degree relatives have an increased burden of moderate-size CNVs (both deletions and duplications) than population controls. However, in contrast to that reported for other neurodevelopmental disorders, we propose that the majority of copy number effects in SLI are conferred by common inherited events. It has previously been proposed that the burden and size of CNVs correlates with the severity of disorder^[@bib10]^ and our results fit this model. The increased burden observed for our cases is not as extreme as that described for autism and intellectual disability but contrasts with studies of developmental dyslexia, where no increased burden was found. Furthermore, our findings correspond with the prototypical complex disorder model in which multiple events contribute only a small effect upon the overall phenotype. In SLI, unlike autism, it is unusual to observe isolated cases within families and family members often present with other language and/or reading difficulties. Our model therefore suggests that common inherited events that contribute to SLI may be relevant to other language-related disorders such as dyslexia. The risk of an individual is determined by the specific combination of events that hit contributory loci, in combination with other genetic and environmental risk factors. It should be noted that this exploratory study used a relatively small, but well characterised, cohort. Larger sample sizes will be required to confirm the trends observed here. New technologies such as next generation paired-end sequencing will be able to detect CNVs at a higher resolution than is currently possible with SNP genotyping arrays allowing a more detailed picture of the CNV burden in larger sample sets.
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###### Burden analysis for (a) all CNVs; (b) deletions; (c) duplications in independent cases compared with population controls

                                                                                 *No. of CNVs*   *Average no. of CNVs per individual*   *Proportion of sample with one or more CNV*   *Average total length of CNVs spanned per individual (kb)*   *Average CNV size (kb)*   *Average no. of genes spanned by CNVs per individual*   *Proportion of CNVs containing at least one gene*   *Average no. of genes per total CNV (kb)*
  ----------------------------------------------------------------------------- --------------- -------------------------------------- --------------------------------------------- ------------------------------------------------------------ ------------------------- ------------------------------------------------------- --------------------------------------------------- -------------------------------------------
  *Total Burden*                                                                                                                                                                                                                                                                                                                                                                        
   Independent cases and population controls                                                                                                                                                                                                                                                                                                                                            
    Cases                                                                            1432                     **11.28**                                      1                                                **717.4**                                   **63.75**                                **14.29**                                               0.95                                            0.02
    Controls                                                                         2693                     **10.01**                                      1                                                **513.9**                                   **51.55**                                **10.34**                                               0.99                                            0.02
    Empirical *P*-value                                                                                       **0.003**                                      1                                                **0.0001**                                 **0.0005**                               **0.0007**                                                 1                                             0.95
   All SLIC family members and population controls                                                                                                                                                                                                                                                                                                                                      
    Family members                                                                   4081                      **10.6**                                                                                       **720.3**                                   **70.09**                                **12.84**                                                                                                  
    Controls                                                                         2693                     **10.01**                                                                                       **513.9**                                   **51.55**                                **10.34**                                                                                                  
    Empirical *P*-value                                                                                        **0.03**                                                                                       **0.0001**                                 **0.0001**                               **0.0005**                                                                                                  
   Affected SLIC family members and population controls                                                                                                                                                                                                                                                                                                                                 
    Family members                                                                    770                       10.69                                                                                         **773.1**                                   **77.26**                                **12.46**                                                                                                  
    Controls                                                                         2693                       10.01                                                                                         **513.9**                                   **51.55**                                **10.34**                                                                                                  
    Empirical *P*-value                                                                                          0.08                                                                                         **0.0001**                                 **0.0001**                                **0.02**                                                                                                   
   Unaffected SLIC family members and population controls                                                                                                                                                                                                                                                                                                                               
    Family members                                                                    501                       10.89                                                                                         **792.2**                                   **71.24**                                **13.85**                                                                                                  
    Controls                                                                         2693                       10.01                                                                                         **513.9**                                   **51.55**                                **10.34**                                                                                                  
    Empirical *P*-value                                                                                          0.07                                                                                         **0.0002**                                 **0.0001**                                **0.005**                                                                                                  
   Independent cases selected on the basis of low NWR and population controls                                                                                                                                                                                                                                                                                                           
    Cases                                                                             674                     **11.42**                                      1                                                 **704**                                    **60.46**                                **12.51**                                               0.95                                            0.02
    Controls                                                                         2693                     **10.01**                                      1                                                **513.9**                                   **51.55**                                **10.34**                                               0.99                                            0.02
    Empirical *P*-value                                                                                       **0.004**                                      1                                                **0.0004**                                  **0.03**                                 **0.03**                                                  1                                             0.92
                                                                                                                                                                                                                                                                                                                                                                                                              
  *Deletions*                                                                                                                                                                                                                                                                                                                                                                           
   Independent cases *vs* controls                                                                                                                                                                                                                                                                                                                                                      
    Cases                                                                            1027                      **8.09**                                      1                                                 **356**                                    **45.19**                                 **7.8**                                                0.92                                            0.03
    Controls                                                                         1878                      **6.98**                                      1                                                **236.4**                                   **34.77**                                 **5.6**                                                0.94                                            0.03
    Empirical *P*-value                                                               ---                     **0.001**                                      1                                                **0.0001**                                 **0.0003**                               **0.0007**                                               0.86                                            0.64
   All SLIC family members and population controls                                                                                                                                                                                                                                                                                                                                      
    Family members                                                                   2995                      **7.78**                                                                                       **344.8**                                   **45.51**                                **7.44**                                                                                                   
    Controls                                                                         1878                      **6.98**                                                                                       **236.4**                                   **34.77**                                 **5.6**                                                                                                   
    Empirical *P*-value                                                               ---                     **0.002**                                                                                       **0.0001**                                 **0.0001**                               **0.0005**                                                                                                  
   Affected SLIC family members and population controls                                                                                                                                                                                                                                                                                                                                 
    Family members                                                                    546                        7.58                                                                                         **352.9**                                   **49.3**                                 **6.96**                                                                                                   
    Controls                                                                         1878                        6.98                                                                                         **236.4**                                   **34.77**                                 **5.6**                                                                                                   
    Empirical *P*-value                                                                                          0.07                                                                                         **0.0001**                                 **0.0002**                                **0.04**                                                                                                   
   Unaffected SLIC family members and population controls                                                                                                                                                                                                                                                                                                                               
    Family members                                                                    364                      **7.91**                                                                                       **376.2**                                   **46.81**                                **8.59**                                                                                                   
    Controls                                                                         1878                      **6.98**                                                                                       **236.4**                                   **34.77**                                 **5.6**                                                                                                   
    Empirical *P*-value                                                                                        **0.03**                                                                                       **0.0001**                                  **0.002**                                **0.002**                                                                                                  
                                                                                                                                                                                                                                                                                                                                                                                                              
  *Duplications*                                                                                                                                                                                                                                                                                                                                                                        
   Independent cases *vs* controls                                                                                                                                                                                                                                                                                                                                                      
    Cases                                                                             401                        3.16                                      0.91                                               **392.5**                                   **121.7**                                  6.44                                                  0.76                                            0.02
    Controls                                                                          813                        3.02                                      0.96                                               **286.4**                                   **89.41**                                  4.72                                                  0.86                                            0.03
    Empirical *P*-value                                                               ---                        0.31                                      0.99                                               **0.003**                                   **0.005**                                  0.07                                                    1                                             0.97
   All SLIC family members and population controls                                                                                                                                                                                                                                                                                                                                      
    Family members                                                                   1072                                                                                                                     **393.3**                                    **129**                                                                                                                                            
    Controls                                                                          813                                                                                                                     **286.4**                                   **89.41**                                                                                                                                           
    Empirical *P*-value                                                               ---                                                                                                                     **0.0004**                                 **0.0001**                                                                                                                                           
   Affected SLIC family members and population controls                                                                                                                                                                                                                                                                                                                                 
    Family members                                                                    223                                                                                                                     **442.7**                                   **124.5**                                                                                                                                           
    Controls                                                                          813                                                                                                                     **286.4**                                   **89.41**                                                                                                                                           
    Empirical *P*-value                                                                                                                                                                                       **0.0009**                                  **0.004**                                                                                                                                           
   Unaffected SLIC family members and population controls                                                                                                                                                                                                                                                                                                                               
    Family members                                                                    132                                                                                                                     **442.6**                                   **119.6**                                                                                                                                           
    Controls                                                                          813                                                                                                                     **286.4**                                   **89.4**                                                                                                                                            
    Empirical *P*-value                                                                                                                                                                                        **0.01**                                   **0.03**                                                                                                                                            

Abbreviations: CNV, copy number variant; NWR, non-word repetition; SLIC, specific language impairment Consortium.

Those metrics that differed significantly between independent cases and population controls were then examined further in affected first-degree relatives and all first-degree relatives compared with population controls. In [Table 1](#tbl1){ref-type="table"}, an alternative definition of affection was also explored; independent cases were selected on the basis of NWR \>1.5 SD below that expected for their age. Categories in bold had a *P-*value \<0.05.

###### Burden analysis for (a) 'rare and novel\' CNVs and deletions; (b) duplications in independent cases compared with population controls

                                                            *No. of CNVs*   *Average no. of CNVs per individual*   *Proportion of sample with one or more CNV*    *Average total length of CNVs spanned per individual (kb)*  *Average CNV size (kb)*   *Average no. of genes spanned by CNVs per individual*   *Proportion of CNVs containing at least one gene*   *Average no. of genes per total CNV (kb)*
  --------------------------------------------------------- --------------- -------------------------------------- --------------------------------------------- ------------------------------------------------------------ ------------------------- ------------------------------------------------------- --------------------------------------------------- -------------------------------------------
  *Total burden*                                                                                                                                                                                                                                                                                                                                                    
   All CNVs in independent cases *vs* controls                                                                                                                                                                                                                                                                                                                      
    Cases                                                   131             1.03                                   0.58                                                                     102.4                             55.42                     2                                                       0.41                                                0.05
    Controls                                                275             1.02                                   0.63                                                                     77.56                             47.4                      0.99                                                    0.41                                                0.07
    Empirical *P*-value                                     ---             0.47                                   0.85                                                                      0.08                             0.13                      0.08                                                    0.54                                                0.59
                                                                                                                                                                                                                                                                                                                                                                     
  *Deletions*                                                                                                                                                                                                                                                                                                                                                       
   Deletions in independent cases *vs* controls                                                                                                                                                                                                                                                                                                                     
    Cases                                                   61              0.48                                   0.38                                                                     42.47                             33.31                     0.46                                                    0.24                                                0.07
    Controls                                                177             0.66                                   0.46                                                                      62.6                             46.36                     0.52                                                    0.26                                                0.05
    Empirical *P*-value                                     ---             0.98                                   0.96                                                                      0.98                             0.95                      0.7                                                     0.74                                                0.21
                                                                                                                                                                                                                                                                                                                                                                     
  *Duplications*                                                                                                                                                                                                                                                                                                                                                    
   Independent cases *vs* controls                                                                                                                                                                                                                                                                                                                                  
    Cases                                                   67              0.53                                   0.29                                                                    **142**                            **88.12**                 1.5                                                     0.22                                                0.03
    Controls                                                97              0.36                                   0.3                                                                    **65.95**                           **53.72**                 0.45                                                    0.18                                                0.11
    Empirical *P*-value                                     ---             0.14                                   0.59                                                                   **0.004**                           **0.006**                 0.06                                                    0.2                                                 0.86
   All SLIC family members and population controls                                                                                                                                                                                                                                                                                                                  
    Family members                                          98                                                                                                                            **92.23**                           **76.44**                                                                                                                              
    Controls                                                97                                                                                                                            **65.95**                           **53.72**                                                                                                                              
    Empirical *P*-value                                                                                                                                                                    **0.03**                           **0.02**                                                                                                                               
   Affected SLIC family members and population controls                                                                                                                                                                                                                                                                                                             
    Family members                                          22                                                                                                                              95.71                             89.66                                                                                                                                  
    Controls                                                97                                                                                                                              65.95                             53.72                                                                                                                                  
    Empirical *P*-value                                                                                                                                                                      0.12                             0.08                                                                                                                                   
   Unaffected SLIC family members and population controls                                                                                                                                                                                                                                                                                                           
    Family members                                          18                                                                                                                              92.32                             67.32                                                                                                                                  
    Controls                                                97                                                                                                                              65.95                             53.72                                                                                                                                  
    Empirical *P*-value                                                                                                                                                                      0.15                             0.22                                                                                                                                   

Abbreviations: CNV, copy number variant; SLIC, specific language impairment Consortium.

As no significant differences were found for the total burden and deletion burden of 'rare and novel\' CNVs, only independent cases *vs* controls are shown in this table.

Those metrics which differed significantly between independent cases and population controls were then examined further in affected first-degree relatives, unaffected first-degree relatives and all first-degree relatives compared with population controls. Categories in bold had a *P-*value \<0.05. Although the affected- and unaffected-only family members did not reach significance, similar trends were seen within these smaller groups.

###### Rare and novel events \>100 kbp and all *de novo* CNVs in independent cases

  *Category of CNV*    *Individual*          *Position (hg19)*          *No. of SNPs*   *Confidence score*                                                  *Genes*                                                  *Intron/exon*  *No. of cases with overlap CNVs (%)*    *No. of overlap CNVs in SLIC first-degree relatives (%)*   *No. of overlap CNVs in population controls (%)*  *Overlap CNVs in DGV?*
  ------------------- -------------- ---------------------------------- --------------- -------------------- ------------------------------------------------------------------------------------------------------ --------------- -------------------------------------- ---------------------------------------------------------- -------------------------------------------------- ------------------------
  Rare                   SLI-42_2     chr11:g.122455520_122675454*dup*  105             27                                                                 *UBASH3B*                                                    Exonic      2 (1.6)                                                            0                                                      0                           
  *De novo*              SLI-45_2      chr2:g.65486928_66364645*del*    282             691                                                              *ACTR2,SPRED2*                                                 Exonic      1 (0.8)                                                            0                                                      0                          Yes
  *De novo*              SLI-59_3       chr8:g.9637318_10340111*dup*    298             19                                                       *LOC157627,MIR124-1,MSRA,TNKS*                                         Exonic      1 (0.8)                                                            0                                                      0                          Yes
  *De novo*              SLI-63_3     chr4:g.120289042_120381341*del*   6               17                                                            *FLJ14186,LOC645513*                                              Exonic      1 (0.8)                                                            0                                                      0                          Yes
  Rare                   SLI-71_2      chr7:g.81788703_81926808*del*    53              183                                                                *CACNA2D1*                                                   Exonic      1 (0.8)                                                         1 (0.3)                                                   0                           
  Rare                   SLI-72_2      chr13:g.92408505_92524032*del*   22              70                                                                   *GPC5*                                                     Exonic      1 (0.8)                                                         6 (1.6)                                                   0                           
  Rare                   SLI-77_4     chr5:g.123502228_123623533*del*   34              78                                                                   *---*                                                       *---*      1 (0.8)                                                         2 (0.5)                                                   0                           
  Rare                   SLI-77_4      chrX:g.64346959_64764336*dup*    16              22                                                              *LAS1L,ZC3H12B*                                                 Exonic      1 (0.8)                                                            0                                                      0                           
  Rare                   SLI-88_3      chr9:g.13774329_13919229*del*    73              257                                                                  *---*                                                       *---*      1 (0.8)                                                         2 (0.5)                                                2 (0.7)                        
  Novel                  SLI-89_2     chr2:g.201766236_201943431*dup*   14              25                                                        *FAM126B,NDUFB3,NIF3L1,ORC2*                                          Exonic      1 (0.8)                                                         1 (0.3)                                                   0                           
  Novel                  SLI-90_2     chr2:g.201823460_201943431*dup*   10              13                                                           *FAM126B,NDUFB3,ORC2*                                              Exonic      1 (0.8)                                                         1 (0.3)                                                   0                           
  Novel                  SLI-90_2      chr11:g.91486518_91668678*del*   57              138                                                                  *---*                                                       *---*      1 (0.8)                                                            0                                                      0                           
  Rare                   SLI-93_3      chr10:g.17080633_17211383*dup*   61              135                                                              *CUBN,TRDMT1*                                                  Exonic      1 (0.8)                                                         2 (0.5)                                                   0                           
  Rare                   SLI-95_2      chr17:g.19998377_20103560*del*   13              14                                                                  *SPECC1*                                                    Exonic      1 (0.8)                                                         1 (0.3)                                                1 (0.4)                        
  Novel                  SLI-95_2      chrX:g.91230696_91335411*dup*    5               11                                                                 *PCDH11X*                                                   Intronic     3 (2.4)                                                         1 (0.3)                                                1 (0.4)                        
  Novel                 SLI-110_2      chr2:g.98620765_98814054*dup*    47              95                                                                  *VWA3B*                                                     Exonic      1 (0.8)                                                            0                                                      0                           
  Rare                  SLI-111_3      chr13:g.46168409_46274638*dup*   23              43                                                                 *FAM194B*                                                    Exonic      1 (0.8)                                                         1 (0.3)                                                   0                           
  Rare                  SLI-112_3      chr5:g.15770553_15921693*dup*    28              55                                                                  *FBXL7*                                                    Intronic     1 (0.8)                                                         1 (0.3)                                                   0                           
  Rare                  SLI-121_2     chr11:g.122430752_122684597*dup*  120             33                                                                 *UBASH3B*                                                    Exonic      2 (1.6)                                                            0                                                      0                           
  Rare                  SLI-141_1      chrX:g.73422412_73564051*dup*    12              16                                            *FTX,MIR374A,MIR374B,MIR374C,MIR421,MIR545,ZCCHC13*                               Exonic      1 (0.8)                                                            0                                                      0                           
  Rare                  SLI-144_3      chrX:g.35827927_36025401*dup*    30              53                                                                 *CXorf22*                                                    Exonic      1 (0.8)                                                         1 (0.3)                                                   0                           
  *De novo*             SLI-146_3     chr5:g.148883634_148903068*del*   8               13                                                                 *CSNK1A1*                                                    Exonic      1 (0.8)                                                            0                                                      0                          Yes
  *De novo*             SLI-146_3      chr22:g.21105255_21463730*dup*   119             185                   *AIFM3,BCRP2,CRKL,LOC400891,LZTR1,TUBA3FP,P2RX6,P2RX6P,PI4KA,SERPIND1,SLC7A4,SNAP29,THAP7,THAP7-AS1*      Exonic      1 (0.8)                                                            0                                                      0                          Yes
  Rare                  SLI-148_2      chr15:g.61751304_61870836*dup*   56              116                                                                  *---*                                                       *---*      1 (0.8)                                                            0                                                      0                           
  Rare                  SLI-156_3      chr4:g.76712173_76824078*dup*    28              57                                                                *PPEF2,USO1*                                                  Exonic      1 (0.8)                                                         2 (0.5)                                                   0                           

Abbreviations: CNV, copy number variant; SLIC, specific language impairment Consortium; SNP, single-nucleotide polymorphism.

Numbers in brackets are frequencies (%).

###### Pathway analysis output of GO terms for genes present in all CNVs and the rare and novel CNVs of independent cases

                                                             *GO category*                                       *No. of reference genes in the category*   *No. of genes in the gene set and also in the category*   *Expected no. in the category*   *Ratio of enrichment*   *Raw* P*-value*   P*-value adjusted for multiple testing*
  --------------------- ---------------------------------------------------------------------------------------- ------------------------------------------ --------------------------------------------------------- -------------------------------- ----------------------- ----------------- -----------------------------------------
  All CNVs                  Molecular function -- cyclic-nucleotide phosphodiesterase activity -- GO:0004112     25                                         5                                                         0.7                              7.11                    0.0006            0.04
  All CNVs                             Molecular function -- acetylcholine binding -- GO:0042166                 13                                         4                                                         0.37                             10.94                   0.0004            0.04
  All CNVs               Molecular function -- 3′,5′-cyclic-nucleotide phosphodiesterase activity -- GO:0004114  24                                         5                                                         0.68                             7.41                    0.0005            0.04
  All CNVs                              Cellular component -- MHC protein complex -- GO:0042611                  38                                         6                                                         1.09                             5.53                    0.0007            0.048
  Rare and novel CNVs               Cellular component -- proteasome activator complex -- GO:0008537             3                                          2                                                         0.02                             84.21                   0.0002            0.034
  Rare and novel CNVs                  Cellular component -- nuclear inclusion body -- GO:0042405                4                                          2                                                         0.03                             63.16                   0.0004            0.034

Abbreviations: CNV, copy number variant; GO, gene ontology.

GO categories are listed that did not occur in population controls and survived multiple testing.

[^1]: A list of SLIC members is provided before References.

[^2]: **Members of the SLI Consortium** R Nudel, AP Monaco (Wellcome Trust Centre for Human Genetics, University of Oxford); E Simonoff, PF Bolton, A Pickles (Institute of Psychiatry, London); V Slonims, K Dworzynski (Newcomen Centre, Guy\'s Hospital); A Everitt (Department of Child Health, University of Aberdeen); A Clark, J Watson (Speech and Hearing Sciences, Queen Margaret University College); J Seckl (Molecular Medicine Centre, University of Edinburgh); H Cowie (Department of Speech and Language Therapy, Royal Hospital for Sick Children, Edinburgh); W Cohen (School of Psychological Sciences and Health, University of Strathclyde); J Nasir (Clinical Developmental Sciences, St George\'s University of London); DVM Bishop (Department of Experimental Psychology, University of Oxford); Z Simkin (Human Communication and Deafness, School of Psychological Sciences, University of Manchester).
